Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials

References

• Anton, S. D., C. Embry, M. Marsiske, X. Lu, H. Doss, C. Leeuwenburgh, and T. M. Manini. 2014. Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study. Experimental Gerontology 57:181–7.
   PubMed Web of Science ®Google Scholar
• Antza, C., I. Doundoulakis, S. Stabouli, and V. Kotsis. 2017. Comparison among recommendations for the management of arterial hypertension issued by last US, Canadian, British and European Guidelines. High Blood Pressure & Cardiovascular Prevention 2017 Nov 1. doi: 10.1007/s40292-017-0236-x. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Amri, A., J. C. Chaumeil, S. Sfar, and C. Charrueau. 2012. Administration of resveratrol: What formulation solutions to bioavailability limitations? Journal of Controlled Release 158:182–93;
   PubMed Web of Science ®Google Scholar
• Bhatt, J. K., S. Thomas, and M. J. Nanjan. 2012. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutrition Research 32:537–41.
   PubMed Web of Science ®Google Scholar
• Borenstein, M., L. Hedges, J. Higgins, and H. Rothstein. 2005. Comprehensive meta-analysis version 3. Englewood, NJ. Biostatistics 2005:104.
   Google Scholar
• Borghi, C., and A. F. Cicero. 2017. Nutraceuticals with a clinically detectable blood pressure-lowering effect: A review of available randomized clinical trials and their meta-analyses. British Journal of Clinical Pharmacology 83:163–171.
   PubMed Web of Science ®Google Scholar
• Burnier, M. 2017. Drug adherence in hypertension. Pharmacological Research 125:142–149.
   PubMed Web of Science ®Google Scholar
• Chachay, V. S., G. A. Macdonald, J. H. Martin, J. P. Whitehead, T. M. O'Moore-Sullivan, P. Lee, M. Franklin, K. Klein, P. J. Taylor, M. Ferguson, et al. 2014. Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology 12:2092–103. e1–6.
   PubMed Web of Science ®Google Scholar
• Chen, S., X. Zhao, L. Ran, J. Wan, X. Wang, Y. Qin, F. Shu, Y. Gao, L. Yuan, Q. Zhang, and M. Mi. 2015. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Digestive and Liver Disease 47:226–32.
   Web of Science ®Google Scholar
• Cicero, A. F., F. Fogacci, and A. Colletti. 2017a. Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach. Food and Function 8:2076–2088.
   PubMed Web of Science ®Google Scholar
• Cicero, A. F., A. Colletti, G. Bajraktari, O. Descamps, D. M. Djuric, M. Ezhov, Z. Fras, N. Katsiki, M. Langlois, G. Latkovskis, et al. 2017b. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Archives of Medical Science 13: 965–1005.
   PubMed Web of Science ®Google Scholar
• Cicero, A. F., and A. Colletti. 2015. Nutraceuticals and blood pressure control: results from clinical trials and meta-analyses. High Blood Pressure and Cardiovascular Prevention 22:203–13.
   PubMed Web of Science ®Google Scholar
• Duval, S., and R. Tweedie. 2000. Trim and fill: a simple funnel‐plot–based method of testing and adjusting for publication bias in meta‐analysis. Biometrics 56:455–63.
   PubMed Web of Science ®Google Scholar
• Faghihzadeh, F., P. Adibi, and A. Hekmatdoost. 2015. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. British Journal of Nutrition 114:796–803.
   PubMed Web of Science ®Google Scholar
• Fogacci, F., A. F. G. Cicero, G. Derosa, M. Rizzo, M. Veronesi, and C. Borghi. 2017. Effect of pistachio on brachial artery diameter and flow-mediated dilatation: a systematic review and meta-analysis of randomized, controlled-feeding clinical studies. Critical Reviews in Food Science and Nutrition 30:0.
   Google Scholar
• Follmann, D., P. Elliott, I. Suh, and J. Cutler. 1992. Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology 45:769–73.
   PubMed Web of Science ®Google Scholar
• Heebøll, S., M. Kreuzfeldt, S. Hamilton-Dutoit, M. Kjær Poulsen, H. Stødkilde-Jørgensen, H. J. Møller, N. Jessen, K. Thorsen, Y. Kristina Hellberg, S. Bønløkke Pedersen, et al. 2016. Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 51:456–64.
   PubMed Web of Science ®Google Scholar
• Higgins, J., S. Green. 2010. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0. 2. 2009. Chichester, UK, John Wiley and Sons Ltd.
   Google Scholar
• Hozo, S. P., B. Djulbegovic, and I. Hozo. 2005. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 5:13.
   PubMedGoogle Scholar
• Imamura, H., T. Yamaguchi, D. Nagayama, A. Saiki, K. Shirai, and I. Tatsuno. 2017. Resveratrol ameliorates arterial stiffness assessed by cardio-ankle vascular index in patients with Type 2 diabetes mellitus. International Heart Journal 58:577–583.
   PubMed Web of Science ®Google Scholar
• Kumar, B. J., and N. M. Joghee. 2013. Resveratrol supplementation in patients with type 2 diabetes mellitus: a prospective, open label, randomized controlled trial. International Research Journal of Pharmacy 4:245–249.
   Google Scholar
• Kjær, T. N., M. J. Ornstrup, M. M. Poulsen, H. Stødkilde-Jørgensen, N. Jessen, J. O. L. Jørgensen, B. Richelsen, and S. B. Pedersen. 2017. No beneficial effects of resveratrol on the metabolic syndrome: a randomized placebo-controlled clinical trial. The Journal of Clinical Endocrinology and Metabolism 102:1642–1651.
   PubMed Web of Science ®Google Scholar
• Li, H., N. Xia, and U. Förstermann. 2012. Cardiovascular effects and molecular targets of resveratrol. Nitric oxide 26:102–10.
   PubMed Web of Science ®Google Scholar
• Liu, Y., W. Ma, P. Zhang, S. He, and D. Huang. 2015. Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials. Clinical Nutrition 34: 27–34.
   PubMed Web of Science ®Google Scholar
• Méndez-del Villar, M., M. González-Ortiz, E. Martínez-Abundis, K. G. Pérez-Rubio, and R. Lizárraga-Valdez. 2014. Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metabolic Syndrome and Related Disorders 12:497–501.
   PubMed Web of Science ®Google Scholar
• Moher, D., A. Liberati, J. Tetzlaff, and D. G. Altman, P. R. I. S. M. A. Group. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. The BMJ 339:b2535.
   PubMed Web of Science ®Google Scholar
• Movahed, A., I. Nabipour, X. Lieben Louis, S. J. Thandapilly, L. Yu, M. Kalantarhormozi, S. J. Rekabpour, and T. Netticadan. 2013. Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evidence-Based Complementary and Alternative Medicine 2013:851267.
   PubMed Web of Science ®Google Scholar
• Newman, J. D., A. Z. Schwartzbard, H. S. Weintraub, I. J. Goldberg, and J. S. Berger. 2017. Primary prevention of cardiovascular disease in diabetes mellitus. Journal of the American College of Cardiology 70:883–893.
   PubMed Web of Science ®Google Scholar
• Ornstrup, M. J., T. Harsløf, T. N. Kjær, B. L. Langdahl, and S. B. Pedersen. 2014. Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial. The Journal of Clinical Endocrinology and Metabolism 99:4720–9.
   PubMed Web of Science ®Google Scholar
• Rochlani, Y., M. H. Khan, and W. S. Aronow. 2017. Managing hypertension in patients aged 75 years and older. Current Hypertension Reports 19:88.
   PubMed Web of Science ®Google Scholar
• Sahebkar, A., M. Pirro, M. Banach, D. P. Mikhailidis, S. L. Atkin, and A. F. G. Cicero. 2017. Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition 13:1–8.
   Web of Science ®Google Scholar
• Sahebkar, A., Ž. Reiner, L. E. Simental-Mendía, G. Ferretti, and A. F. Cicero. 2016. Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials. Metabolism 65:1664–1678.
   PubMed Web of Science ®Google Scholar
• Sahebkar, A., C. Serban, S. Ursoniu, N. D. Wong, P. Muntner, I. M. Graham, D. P. Mikhailidis, M. Rizzo, J. Rysz, L. S. Sperling, G. Y. Lip, and M. Banach, Lipid and Blood Pressure Meta-analysis Collaboration Group. 2015. Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors–Results from a systematic review and meta-analysis of randomized controlled trials. International Journal of Cardiology 189: 47–55.
   PubMed Web of Science ®Google Scholar
• Serban, M. C., A. Sahebkar, A. Zanchetti, D. P. Mikhailidis, G. Howard, D. Antal, F. Andrica, A. Ahmed, W. S. Aronow, P. Muntner, G. Y. Lip, I. Graham, N. Wong, J. Rysz, and M. Banach, Lipid and Blood Pressure Meta‐analysis Collaboration (LBPMC) Group. 2016. Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Journal of the American Heart Association 5: pii: e002713.
   PubMed Web of Science ®Google Scholar
• Sergides, C., M. Chirilă, L. Silvestro, D. Pitta, and A. Pittas. 2016. Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers. Experimental and Therapeutic Medicine 11:164–170.
   PubMed Web of Science ®Google Scholar
• Sirtori, C. R., A. Arnoldi, and A. F. Cicero. 2015. Nutraceuticals for blood pressure control. Annals of Medicine 47:447–56.
   PubMed Web of Science ®Google Scholar
• Sosnowska, B., P. Penson, and M. Banach. The role of nutraceuticals in the prevention of cardiovascular disease. 2017. Cardiovascular Diagnosis and Therapy 7(Suppl 1):S21–S31.
   PubMedGoogle Scholar
• Tomé-Carneiro, J., M. Gonzálvez, M. Larrosa, M. J. Yáñez-Gascón, F. J. García-Almagro, J. A. Ruiz-Ros, F. A. Tomás-Barberán, M. T. García-Conesa, and J. C. Espín. 2013. Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovascular Drugs and Therapy 27:37–48.
   PubMed Web of Science ®Google Scholar
• Timmers, S., M. de Ligt, E. Phielix, T. van de Weijer, J. Hansen, E. Moonen-Kornips, G. Schaart, I. Kunz, M. K. Hesselink, V. B. Schrauwen-Hinderling, et al. 2016. Resveratrol as add-on therapy in subjects with well-controlled type 2 diabetes: a randomized controlled trial. Diabetes Care 39:2211–2217.
   PubMedGoogle Scholar
• Timmers, S., E. Konings, L. Bilet, R. H. Houtkooper, T. van de Weijer, G. H. Goossens, J. Hoeks, S. van der Krieken, D. Ryu, S. Kersten, et al. 2011. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metabolism 14:612–22.
   PubMed Web of Science ®Google Scholar
• van der Made, S. M., J. Plat, and R. P. Mensink. 2015. Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial. PLoS One 10:e0118393.
   PubMed Web of Science ®Google Scholar
• Walle, T., F. Hsieh, M. H. DeLegge, J. E. Oatis Jr, and U. K. Walle. 2004. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition 32:1377–82. Epub 2004 Aug 27;
   PubMed Web of Science ®Google Scholar
• Walle, T. 2011. Bioavailability of resveratrol. Annals of the New York Academy of Sciences 2011;1215:9–15.
   PubMed Web of Science ®Google Scholar
• Wong, R. H., N. M. Berry, A. M. Coates, J. D. Buckley, J. Bryan, I. Kunz, and P. R. Howe. 2013. Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. Journal of Hypertension 31:1819–27.
   PubMed Web of Science ®Google Scholar
• Yoshino, J., C. Conte, L. Fontana, B. Mittendorfer, S. Imai, K. B. Schechtman, C. Gu, I. Kunz, F. Rossi Fanelli, B. W. Patterson, et al. 2012. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metabolism 16:658–64.
   PubMed Web of Science ®Google Scholar
• Zhu, X., C. Wu, S. Qiu, X. Yuan, and L. Li. 2017. Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis. Nutrition and Metabolism 14:60.
   Google Scholar